Clinical Trials Logo

Clinical Trial Summary

The primary purpose of this study was to assess the effectiveness of omega-3 supplementation on behavior problems in children.


Clinical Trial Description

This study consists of a randomized, placebo-controlled, double-blind trial of omega-3 on behavior problems in children. All behavior problem outcomes were assessed, although the primary focus was on antisocial and aggressive behavior. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02016079
Study type Interventional
Source Joint Child Health Project, Mauritius
Contact
Status Completed
Phase Phase 2/Phase 3
Start date March 2010
Completion date December 2011

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02633111 - DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Completed NCT04648553 - Task-Based Grounding Program Phase 1